HRT Financial’s 60 Degrees Pharmaceuticals SXTP Stock Holding History

HRT Financial’s Portfolio SXTP Stock Details SXTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-630	Closed	-$16K	–	3358
2024 Q4	$16K	Buy	+630	New	+$13.9K	﹤0.01%	2237
2024 Q3	–	Sell	-120	Closed	-$7K	–	3111
2024 Q2	$7K	Buy	+120	New	+$7.62K	﹤0.01%	2019

Other funds holding SXTP

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

SHF

Safe Harbor Fiduciary Pensacola, Florida $105M AUM

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

HRT Financial's SXTP Position: Q1 2025 in Review

HRT Financial sold out of 60 Degrees Pharmaceuticals (SXTP) in Q1 2025, closing a stake of 630 shares — an estimated $16K sold.

HRT Financial first reported a position in SXTP in Q2 2024 and held it in 2 quarters. The position peaked at $16K in Q4 2024. 6 funds tracked by Wall St. Rank hold SXTP as of Q1 2025.

HRT Financial reported no remaining 60 Degrees Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
HRT Financial sold 630 60 Degrees Pharmaceuticals shares in Q1 2025, an estimated $16K.
HRT Financial first reported a position in 60 Degrees Pharmaceuticals in Q2 2024 and held it in 2 quarters.
HRT Financial's 60 Degrees Pharmaceuticals position peaked at $16K in Q4 2024.
6 funds tracked by Wall St. Rank held 60 Degrees Pharmaceuticals as of Q1 2025.

Based on HRT Financial's 13F filing for Q1 2025, filed 15 May 2025.